Keyphrases
Zoledronic Acid
100%
Bisphosphonates
100%
Antitumor Activity
100%
Metastasis to Bone
100%
Bone Metastasis
60%
Angiogenesis
40%
Clodronate
40%
Multiple Myeloma
20%
Solid Tumors
20%
Tumor Progression
20%
Adhesion
20%
Clinical Data
20%
Randomized Trial
20%
Treatment Regimen
20%
High Risk
20%
Clinically Significant
20%
Tumor Cells
20%
Vascular Endothelial Growth Factor
20%
Basal Level
20%
Metastatic Bone Disease
20%
Patients with Breast Cancer
20%
Antiangiogenic Properties
20%
Early Generation
20%
Skeletal Metastases
20%
Antitumor Properties
20%
Pharmacology, Toxicology and Pharmaceutical Science
Zoledronic Acid
100%
Bisphosphonic Acid Derivative
100%
Antitumor Activity
100%
Bone Metastasis
80%
Clodronic Acid
40%
Breast Cancer
20%
Solid Malignant Neoplasm
20%
Neoplasm
20%
Multiple Myeloma
20%
Tumor Growth
20%
Clinical Study
20%
Preclinical Study
20%
Overall Survival
20%
Vasculotropin
20%
Bone Disease
20%
Antiangiogenic
20%